SelectQuote's licensed insurance agents provide honest, no-pressure support to help you understand your options and select ...

The company unveiled its latest set of quarterly earnings. It showed robust growth, but a Department of Justice complaint is dogging its stock. For its fiscal third quarter of 2025, SelectQuote reaped ...

It is a pleasure to report that the SelectQuote, Inc. (NYSE:SLQT) is up 55% in the last quarter. But that is meagre solace when you consider how the price has plummeted over the last year.

SelectQuote Inc. Annual cash flow by MarketWatch. View SLQT net cash flow, operating cash flow, operating expenses and cash dividends.

Key Insights Significantly high institutional ownership implies SelectQuote's stock price is sensitive to their ...

At the heart of the complaint are claims that SelectQuote misrepresented its Medicare Advantage sales practices. While the company publicly promoted its services as offering "unbiased advice" and ...

SelectQuote reported earnings for the 2025 fiscal-year second-quarter. The company reported earnings per share of 30 cents, beating analysts' estimate of 10 cents. Ready to turn the market’s comeback ...

I'm upgrading SelectQuote to a buy rating after the stock's recent sharp fall. The federal government recently approved a 5.06% reimbursement rate increase for Medicare Advantage plans, which should ...

Investors might want to bet on SelectQuote (SLQT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...

SelectQuote, Inc. skyrocketed ~30% after posting very strong Q2 results alongside the announcement of a $350 million private infusion from investors led by Bain Capital. Revenue grew 19% ...